OBJECTIVES: Detection of atrial fibrillation (AF) in post-cryptogenic stroke (CS) or transient ischemic attack (TIA) patients carries important therapeutic implications. METHODS: To risk stratify CS/TIA patients for later development of AF, we conducted a retrospective cohort study using data from 1995 to 2015 in the Stanford Translational Research Integrated Database Environment (STRIDE). RESULTS: Of the 9,589 adult patients (age ≥40 years) with CS/TIA included, 482 (5%) patients developed AF post CS/TIA. Of those patients, 28.4, 26.3, and 45.3% were diagnosed with AF 1-12 months, 1-3 years, and >3 years after the index CS/TIA, respectively. Age (≥75 years), obesity, congestive heart failure, hypertension, coronary artery disease, peripheral vascular disease, and valve disease are significant risk factors, with the following respective odds ratios (95% CI): 1.73 (1.39-2.16), 1.53 (1.05-2.18), 3.34 (2.61-4.28), 2.01 (1.53-2.68), 1.72 (1.35-2.19), 1.37 (1.02-1.84), and 2.05 (1.55-2.69). A risk-scoring system, i.e., the HAVOC score, was constructed using these 7 clinical variables that successfully stratify patients into 3 risk groups, with good model discrimination (area under the curve = 0.77). CONCLUSIONS: Findings from this study support the strategy of looking longer and harder for AF in post-CS/TIA patients. The HAVOC score identifies different levels of AF risk and may be used to select patients for extended rhythm monitoring.
OBJECTIVES: Detection of atrial fibrillation (AF) in post-cryptogenic stroke (CS) or transient ischemic attack (TIA) patients carries important therapeutic implications. METHODS: To risk stratify CS/TIApatients for later development of AF, we conducted a retrospective cohort study using data from 1995 to 2015 in the Stanford Translational Research Integrated Database Environment (STRIDE). RESULTS: Of the 9,589 adult patients (age ≥40 years) with CS/TIA included, 482 (5%) patients developed AF post CS/TIA. Of those patients, 28.4, 26.3, and 45.3% were diagnosed with AF 1-12 months, 1-3 years, and >3 years after the index CS/TIA, respectively. Age (≥75 years), obesity, congestive heart failure, hypertension, coronary artery disease, peripheral vascular disease, and valve disease are significant risk factors, with the following respective odds ratios (95% CI): 1.73 (1.39-2.16), 1.53 (1.05-2.18), 3.34 (2.61-4.28), 2.01 (1.53-2.68), 1.72 (1.35-2.19), 1.37 (1.02-1.84), and 2.05 (1.55-2.69). A risk-scoring system, i.e., the HAVOC score, was constructed using these 7 clinical variables that successfully stratify patients into 3 risk groups, with good model discrimination (area under the curve = 0.77). CONCLUSIONS: Findings from this study support the strategy of looking longer and harder for AF in post-CS/TIApatients. The HAVOC score identifies different levels of AF risk and may be used to select patients for extended rhythm monitoring.
Authors: Line Melgaard; Anders Gorst-Rasmussen; Deidre A Lane; Lars Hvilsted Rasmussen; Torben Bjerregaard Larsen; Gregory Y H Lip Journal: JAMA Date: 2015-09-08 Impact factor: 56.272
Authors: Christopher G Favilla; Erin Ingala; Jenny Jara; Emily Fessler; Brett Cucchiara; Steven R Messé; Michael T Mullen; Allyson Prasad; James Siegler; Mathew D Hutchinson; Scott E Kasner Journal: Stroke Date: 2015-04-07 Impact factor: 7.914
Authors: L Brent Mitchell; Danielle A Southern; Diane Galbraith; William A Ghali; Merril Knudtson; Stephen B Wilton Journal: Heart Date: 2014-05-23 Impact factor: 5.994
Authors: B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju Journal: Circulation Date: 1997-10-07 Impact factor: 29.690
Authors: David J Gladstone; Melanie Spring; Paul Dorian; Val Panzov; Kevin E Thorpe; Judith Hall; Haris Vaid; Martin O'Donnell; Andreas Laupacis; Robert Côté; Mukul Sharma; John A Blakely; Ashfaq Shuaib; Vladimir Hachinski; Shelagh B Coutts; Demetrios J Sahlas; Phil Teal; Samuel Yip; J David Spence; Brian Buck; Steve Verreault; Leanne K Casaubon; Andrew Penn; Daniel Selchen; Albert Jin; David Howse; Manu Mehdiratta; Karl Boyle; Richard Aviv; Moira K Kapral; Muhammad Mamdani Journal: N Engl J Med Date: 2014-06-26 Impact factor: 91.245
Authors: Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin Journal: Lancet Date: 2009-02-28 Impact factor: 79.321
Authors: Stephen T Wu; Hongfang Liu; Dingcheng Li; Cui Tao; Mark A Musen; Christopher G Chute; Nigam H Shah Journal: J Am Med Inform Assoc Date: 2012-04-04 Impact factor: 4.497
Authors: Jeff S Healey; David J Gladstone; Balakumar Swaminathan; Jens Eckstein; Hardi Mundl; Andrew E Epstein; Karl Georg Haeusler; Robert Mikulik; Scott E Kasner; Danilo Toni; Antonio Arauz; George Ntaios; Graeme J Hankey; Kanjana Perera; Jorge Pagola; Ashfaq Shuaib; Helmi Lutsep; Xiaomeng Yang; Shinichiro Uchiyama; Matthias Endres; Shelagh B Coutts; Michal Karlinski; Anna Czlonkowska; Carlos A Molina; Gustavo Santo; Scott D Berkowitz; Robert G Hart; Stuart J Connolly Journal: JAMA Neurol Date: 2019-07-01 Impact factor: 18.302
Authors: Marta Rubiera; Ana Aires; Kateryna Antonenko; Sabrina Lémeret; Christian H Nolte; Jukka Putaala; Renate B Schnabel; Anil M Tuladhar; David J Werring; Dena Zeraatkar; Maurizio Paciaroni Journal: Eur Stroke J Date: 2022-06-03
Authors: Jiann-Der Lee; Ya-Wen Kuo; Chuan-Pin Lee; Yen-Chu Huang; Meng Lee; Tsong-Hai Lee Journal: Int J Environ Res Public Health Date: 2022-06-14 Impact factor: 4.614
Authors: Laura Amaya Pascasio; Miguel Quesada López; Juan Manuel García-Torrecillas; Antonio Arjona-Padillo; Patricia Martínez Sánchez Journal: Front Neurol Date: 2022-06-28 Impact factor: 4.086
Authors: Markus Kneihsl; Egbert Bisping; Daniel Scherr; Harald Mangge; Simon Fandler-Höfler; Isabella Colonna; Melanie Haidegger; Sebastian Eppinger; Edith Hofer; Franz Fazekas; Christian Enzinger; Thomas Gattringer Journal: Eur J Neurol Date: 2021-09-23 Impact factor: 6.288
Authors: Michael F Gensheimer; A Solomon Henry; Douglas J Wood; Trevor J Hastie; Sonya Aggarwal; Sara A Dudley; Pooja Pradhan; Imon Banerjee; Eunpi Cho; Kavitha Ramchandran; Erqi Pollom; Albert C Koong; Daniel L Rubin; Daniel T Chang Journal: J Natl Cancer Inst Date: 2019-06-01 Impact factor: 13.506
Authors: Cheng-Yang Hsieh; Hsuan-Min Kao; Kuan-Lin Sung; Luciano A Sposato; Sheng-Feng Sung; Swu-Jane Lin Journal: Front Cardiovasc Med Date: 2022-04-29
Authors: Constanze Schmidt; Sebastian Benda; Patricia Kraft; Felix Wiedmann; Sven Pleger; Antonius Büscher; Dierk Thomas; Rolf Wachter; Christian Schmid; Roland Eils; Hugo A Katus; Stefan M Kallenberger Journal: Clin Res Cardiol Date: 2020-11-19 Impact factor: 5.460